SAFECODE DRUG TECHNOLOGIES CORP. Operating Income
SAFECODE DRUG TECHNOLOGIES CORP. reported Operating Income of -$193.43 thousand for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-13.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2013-08-13
- SAFECODE DRUG TECHNOLOGIES CORP. operating income (loss) for the quarter ending 2013-06-30 was -$193.43K.
- SAFECODE DRUG TECHNOLOGIES CORP. operating income (loss) for the quarter ending 2013-03-31 was -$505.22K.
- SAFECODE DRUG TECHNOLOGIES CORP. operating income (loss) for the quarter ending 2012-12-31 was -$2.00M.
- SAFECODE DRUG TECHNOLOGIES CORP. operating income (loss) for the quarter ending 2012-09-30 was -$21.01K.
- SAFECODE DRUG TECHNOLOGIES CORP. operating income (loss) for fiscal 2012 was -$2.04M.
- SAFECODE DRUG TECHNOLOGIES CORP. operating income (loss) for fiscal 2011 was -$41.86K.
| Period end | Operating Income (Loss) 1 month | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 13 month | Operating Income (Loss) 16 month | Operating Income (Loss) 19 month | Operating Income (Loss) 22 month | Operating Income (Loss) 25 month | Operating Income (Loss) 28 month | Operating Income (Loss) 31 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-06-30 | -$193.43K 10-Q · filed 2013-08-13 | -$698.65K 10-Q · filed 2013-08-13 | -$2.70M derived: sum of 3 quarters · filed 2013-08-13 | -$2.72M derived: sum of 4 quarters · filed 2013-08-13 | -$2.79M 10-Q · filed 2013-08-13 | |||||||
| 2013-03-31 | -$505.22K 10-Q · filed 2013-05-10 | -$2.50M derived: sum of 2 quarters · filed 2013-05-10 | -$2.53M derived: sum of 3 quarters · filed 2013-05-10 | -$2.54M derived: sum of 4 quarters · filed 2013-08-13 | -$2.60M 10-Q · filed 2013-05-10 | |||||||
| 2012-12-31 | -$2.00M derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-25 | -$2.02M derived: sum of 2 quarters · filed 2013-03-25 | -$2.04M derived: sum of 3 quarters · filed 2013-08-13 | -$2.04M 10-K · filed 2013-03-25 | -$2.10M 10-K · filed 2013-03-25 | |||||||
| 2012-09-30 | -$21.01K 10-Q/A · filed 2012-12-18 | -$36.63K derived: sum of 2 quarters · filed 2013-08-13 | -$43.11K 10-Q/A · filed 2012-12-18 | -$69.02K derived: sum of 4 quarters · filed 2013-08-13 | -$96.73K 10-Q/A · filed 2012-12-18 | |||||||
| 2012-06-30 | -$15.63K 10-Q · filed 2013-08-13 | -$22.10K 10-Q · filed 2013-08-13 | -$48.01K derived: sum of 3 quarters · filed 2013-08-13 | -$53.31K derived: sum of 4 quarters · filed 2013-08-13 | -$75.72K 10-Q/A · filed 2012-12-18 | |||||||
| 2012-03-31 | -$6.47K 10-Q · filed 2013-05-10 | -$32.38K derived: sum of 2 quarters · filed 2013-05-10 | -$37.68K derived: sum of 3 quarters · filed 2013-05-10 | -$41.68K derived: sum of 4 quarters · filed 2013-05-10 | -$60.09K 10-Q · filed 2012-05-15 | |||||||
| 2011-12-31 | -$25.91K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-25 | -$31.21K derived: sum of 2 quarters · filed 2013-03-25 | -$35.21K derived: sum of 3 quarters · filed 2013-03-25 | -$41.86K 10-K · filed 2013-03-25 | -$53.62K 10-K · filed 2012-03-29 | |||||||
| 2011-09-30 | -$5.30K 10-Q/A · filed 2012-12-18 | -$9.30K derived: sum of 2 quarters · filed 2012-12-18 | -$15.95K 10-Q/A · filed 2012-12-18 | |||||||||
| 2011-06-30 | -$4.00K 10-Q/A · filed 2012-12-18 | -$10.65K 10-Q/A · filed 2012-12-18 | ||||||||||
| 2011-03-31 | -$6.65K 10-Q · filed 2012-05-15 | |||||||||||
| 2010-12-31 | -$11.76K 10-K · filed 2012-03-29 |